Requires medical assistance to include medical care, services or supplies to monitor blood pressure that have been validated for accuracy and are furnished without prior authorization to eligible pregnant women

2025 Regular Session Introduced by Chantel Jackson

Expands medical assistance to cover blood pressure monitoring for pregnant women, validated for accuracy, removing prior authorization to boost access and consistency of care.

REFERRED TO HEALTH

Summary of Bill A 8946 (2025)

Overview

Bill A 8946 would require medical assistance (i.e., the state-funded health coverage program) to include medical care, services, or supplies used to monitor blood pressure for eligible pregnant women. The items must be validated for accuracy and would be furnished without prior authorization.

Purpose and intent

Improve access to blood pressure monitoring for pregnant women enrolled in medical assistance.

Remove administrative barriers by eliminating the prior authorization step for these BP monitoring-related services and supplies, provided they are validated for accuracy.

Ensure that monitoring equipment and related care are evidence-based and reliable.

Key provisions (as stated)

Coverage addition: Medical assistance must cover medical care, services, or supplies used to monitor blood pressure that have been validated for accuracy.

Prior authorization: Such BP monitoring items and services would be furnished to eligible pregnant women without requiring prior authorization.

Eligibility: Applies to pregnant women who qualify for medical assistance (i.e., those enrolled in the program).

Affected parties

Eligible pregnant women enrolled in the medical assistance program (beneficiaries of the coverage expansion).

Health care providers and suppliers who furnish BP monitoring care, services, or supplies under medical assistance.

The state agency administering medical assistance, which would implement and enforce the new coverage and authorization provisions.

Procedural status and timeline

Introduced: July 16, 2025.

Legislative action: Referred to the Health Committee on July 16, 2025 (record shows two identical entries for this referral).

Companion legislation: S 8541 (listed as a companion bill in the Senate).

Legislative context and notes

The presence of a Senate companion (S 8541) indicates parallel consideration in another chamber.

No explicit effective date, funding mechanism, or definitions of “validated for accuracy” are provided in the available information.

Potential impact and considerations

Positive impact on maternal health outcomes by facilitating consistent BP monitoring during pregnancy through insured coverage.

Administrative simplification for providers and patients by removing prior authorization for validated BP monitoring items.

Uncertain implementation details (e.g., what standards constitute “validated for accuracy,” exact items covered, reimbursement rules, and any cost impacts) not specified in the current summary.

Related bill

S 8541 (companion bill) — indicates cross-chamber alignment and potential broader legislative attention.

If you’d like, I can tailor this summary to a specific audience (health policy professionals, legislators, or the general public) or add a brief comparison to similar existing programs.